AR050949A1 - Derivados de 5,7-dihidro-1h-imidazol [4,5-f]indol o [4,5-g]quinolin-6-ona; su elaboracion y su uso en la preparacion de un medicamentop para el tratamiento del cancer - Google Patents

Derivados de 5,7-dihidro-1h-imidazol [4,5-f]indol o [4,5-g]quinolin-6-ona; su elaboracion y su uso en la preparacion de un medicamentop para el tratamiento del cancer

Info

Publication number
AR050949A1
AR050949A1 ARP050103957A ARP050103957A AR050949A1 AR 050949 A1 AR050949 A1 AR 050949A1 AR P050103957 A ARP050103957 A AR P050103957A AR P050103957 A ARP050103957 A AR P050103957A AR 050949 A1 AR050949 A1 AR 050949A1
Authority
AR
Argentina
Prior art keywords
alkyl
formula
preparation
cancer
hydrogen
Prior art date
Application number
ARP050103957A
Other languages
English (en)
Spanish (es)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR050949A1 publication Critical patent/AR050949A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41881,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP050103957A 2004-09-24 2005-09-21 Derivados de 5,7-dihidro-1h-imidazol [4,5-f]indol o [4,5-g]quinolin-6-ona; su elaboracion y su uso en la preparacion de un medicamentop para el tratamiento del cancer AR050949A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04022753 2004-09-24
EP05010528 2005-05-13

Publications (1)

Publication Number Publication Date
AR050949A1 true AR050949A1 (es) 2006-12-06

Family

ID=35429559

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050103957A AR050949A1 (es) 2004-09-24 2005-09-21 Derivados de 5,7-dihidro-1h-imidazol [4,5-f]indol o [4,5-g]quinolin-6-ona; su elaboracion y su uso en la preparacion de un medicamentop para el tratamiento del cancer

Country Status (10)

Country Link
EP (1) EP1793822A1 (ko)
JP (1) JP2008514565A (ko)
KR (1) KR100845749B1 (ko)
AR (1) AR050949A1 (ko)
AU (1) AU2005287459A1 (ko)
CA (1) CA2580203A1 (ko)
MX (1) MX2007003463A (ko)
RU (1) RU2007115159A (ko)
TW (1) TW200626149A (ko)
WO (1) WO2006032519A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006108489A1 (en) * 2005-04-14 2006-10-19 F. Hoffmann-La Roche Ag Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
JP2009519279A (ja) * 2005-12-15 2009-05-14 エフ.ホフマン−ラ ロシュ アーゲー 三員環ラクタム誘導体、それらの製造方法、及び医薬剤としての使用
US20090291968A1 (en) * 2006-03-23 2009-11-26 Guy Georges Substituted indazole derivatives, their manufacture and use as pharmaceutical agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3501497A1 (de) * 1985-01-18 1986-07-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
US4835280A (en) * 1985-01-18 1989-05-30 Boehringer Mannheim Gmbh Indoline compounds for synthesis of pharmaceutically active pyrrolobenzimidazoles
DE3740985A1 (de) * 1987-12-03 1989-06-15 Boehringer Mannheim Gmbh Verwendung linear anellierter tricyclen als hemmer der erythrozytenaggregation

Also Published As

Publication number Publication date
KR20070045339A (ko) 2007-05-02
MX2007003463A (es) 2007-05-23
JP2008514565A (ja) 2008-05-08
RU2007115159A (ru) 2008-11-10
TW200626149A (en) 2006-08-01
EP1793822A1 (en) 2007-06-13
WO2006032519A1 (en) 2006-03-30
CA2580203A1 (en) 2006-03-30
KR100845749B1 (ko) 2008-07-11
AU2005287459A1 (en) 2006-03-30

Similar Documents

Publication Publication Date Title
AR038419A1 (es) Derivados de piridina y quinolina
PE20220143A1 (es) Agonistas de glp-1r y usos de los mismos
AR064253A1 (es) Compuestos de biciclocarboxiamida sustituidos composiciones farmaceuticas y una combinacion que los incluye y su uso en fabaricacion de un medicamento para el tratamiento de enfermedades mediadas por la actividad del receptor vr1
Kumar et al. Antimycobacterial activity of novel 1, 2, 4-oxadiazole-pyranopyridine/chromene hybrids generated by chemoselective 1, 3-dipolar cycloadditions of nitrile oxides
AR064561A1 (es) Derivados de 2-aza-biciclo[3.1.0]hexano y su uso en la preparacion de un medicamento para el tratamiento de enfermedades relacionadas con disfunciones generales del sistema de la orexina.
AR046297A1 (es) Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo
WO2016071293A2 (en) Pharmaceutical compound
AR035665A1 (es) Imidazoquinolinas y 6,7,8,9-tetrahidroimidazoquinolinas, composiciones farmaceuticas que las comprenden, uso de dichos compuestos en la preparacion de medicamentos, e intermediarios utiles en la sintesis de dichos compuestos
PE20060921A1 (es) Procedimiento para preparar 8-(3-amino-piperidin-1-il)-xantinas quirales
PE20040164A1 (es) Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas
AR061867A1 (es) Derivados de (4,5') bipirimidil 6,4' - diamina como inhibidores de proteinquinasa
AR078756A1 (es) Moduladores alostericos positivos (map)
AR072952A1 (es) Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso
AR046272A1 (es) Inhibidores de dipeptidil peptidasa iv
AR040489A1 (es) Compuestos derivados de 3-fenil-propionamido, 3-fenil-acrilamido y 3-fenil-propinamido, su uso para la elaboracion de medicamentos, un proceso para elaborar los compuestos y medicamentos que los contienen
AR042002A1 (es) Benzoxazinonas sustituidas, proceso de obtencion y usos para tratamiento de enfermedades del sistema nervioso central.
ECSP088257A (es) Derivados de amida
AR042155A1 (es) Aminoalcoxiindoles, composicion farmaceutica que los comprenden y usos
ECSP11011196A (es) Derivados de piperidina
ES2587745T3 (es) Derivados de imidazo[2,1]tiazol-3-ona útiles como agentes de diagnóstico para la enfermedad de Alzheimer
AR050949A1 (es) Derivados de 5,7-dihidro-1h-imidazol [4,5-f]indol o [4,5-g]quinolin-6-ona; su elaboracion y su uso en la preparacion de un medicamentop para el tratamiento del cancer
AR042284A1 (es) Derivados de piperidina, preparacion y composiciones farmaceuticas que las contienen; y uso de los mismos para la fabricacion de medicamentos
AR062941A1 (es) Compuestos para el tratamiento de desordenes metabolicos
AR036735A1 (es) Derivados de 5-metoxi-8-aril-[1,2,4]triazolo[1,5-a]piridina
AR050193A1 (es) Derivados de benciloxi-oxopirrolidina como inhibidores de la mao; metodos para su preparacion y medicamentos para el tratamiento de enfermedades neurodegenerativas que los contienen.

Legal Events

Date Code Title Description
FB Suspension of granting procedure